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Background: Glucagon-like Peptide-1 (GLP-1), an incretin hormone, has been shown to promote myocardial glucose uptake and protect against 
ischemia in animal models. We assessed the hypothesis that GLP-1 infusion would protect the heart from ischemic dysfunction during dobutamine 
stress echocardiography (DSE) in patients with stable angina and coronary artery disease.
Methods: Twelve patients (age 65 ± 9 years) with coronary artery disease and good left ventricular (LV) function awaiting elective revascularisation 
were studied. Two DSE scans were conducted in a randomised order following an overnight fast. GLP-1 (7-36) amide was infused intravenously at 
1.2 pmol/kg/min during one of the scans and the other acted as a control. Tissue Doppler imaging was acquired in three apical views at rest, peak 
stress and 30 minutes into recovery.
Results: There was no difference in rate pressure product between the GLP-1 and control scans (22246 ± 4172 vs 22065 ± 3467; p=0.88). GLP-
1 infusion increased plasma GLP-1 (7-36) (185.9 ± 1.8 vs 6.6 ± 3.7 pg/ml; p<0.0001) and decreased glucose (4.5 ± 1.1 vs 5.3 ± 1.0 mmol/l; 
p<0.0001) at peak stress compared to control. GLP-1 infusion improved global and regional wall LV function at peak stress (Table). There was a 
reduction in function in recovery compared to baseline in the control scan (stunning) which did not occur with GLP-1 infusion.
Conclusion: Infusion of GLP-1 improves global and regional wall LV function during dobutamine stress in patients with coronary artery disease.
Global and regional wall LV function. Vs indicates peak systolic tissue velocity
REST
PEAK 
STRESS
RECOVERY
Control GLP-1 P Value Control GLP-1 P Value Control GLP-1 P Value
Global LV function
Mitral annular 
Vs, cm/s
5.77 ± 1.63 5.70 ± 1.47 0.50
10.88 ± 
3.37
11.97 ± 3.47 0.004 5.47 ± 1.58 5.66 ± 1.43 0.10
Regional wall function (non-apical segments)
Vs, cm/s 4.64 ± 1.84 4.59 ± 1.67 0.57 8.81 ± 3.65 10.03 ± 3.40 <0.0001 4.11 ± 1.81 4.39 ± 1.68 0.008
Strain, % -16.5 ± 6.4 -16.9 ± 7.4 0.65 -13.4 ± 6.2 -16.6 ± 5.7 <0.0001 -15.0 ± 7.0 -17.3 ± 6.7 0.01
Strain Rate, s-1 -1.06 ± 0.42 -1.12 ± 0.50 0.40
-1.94 ± 
0.86
-2.28 ± -1.10 0.004 -0.97 ± 0.44 -1.15 ± 0.48 0.002
